This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Metabrain Research. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Lauren R Faveriel: Innovator in Diabetes Treatment
Introduction
Lauren R Faveriel is a prominent inventor based in Longjumeau, France. She has made significant contributions to the field of diabetes treatment through her innovative research and development of pharmaceutical compounds. Her work focuses on creating effective solutions for managing diabetes and its associated complications.
Latest Patents
Lauren R Faveriel holds a patent for "Useful thiophene derivatives in the treatment of diabetes." This invention relates to a thiophene derivative of a specific general formula, which can exist in various forms such as enantiomers, diastereoisomers, hydrates, solvates, tautomers, racemic mixtures, or pharmaceutically acceptable salts. The primary application of this compound is as a drug intended for treating and preventing diabetes, particularly type II diabetes and hyperglycemia.
Career Highlights
Throughout her career, Lauren has demonstrated a strong commitment to advancing medical science. She is currently associated with Metabrain Research, where she continues to explore innovative approaches to diabetes treatment. Her dedication to research has positioned her as a key figure in her field.
Collaborations
Lauren collaborates with esteemed colleagues, including Franck F Lepifre and Gersande R Lena. These partnerships enhance her research efforts and contribute to the development of groundbreaking solutions in diabetes management.
Conclusion
Lauren R Faveriel is a trailblazer in the field of diabetes treatment, with her innovative patent and collaborative efforts paving the way for future advancements. Her work exemplifies the impact of dedicated research on improving health outcomes for individuals with diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile